Latest News

Rate-hike odds for next week's Fed meeting jumped to 70%.

AeroVironment posted a Q1 revenue and earnings beat with record backlog, prompting Moderate Buy ratings from analysts and price targets implying significant upside from current levels.

AppLovin is one of the most profitable advertising platforms in the market, while Reddit just turned profitable and is building new revenue streams that could broaden its business significantly.

Broadcom's latest quarter revenue hit $29.6 billion — nearly 11 times Marvell's $2.7 billion — with both companies posting steady gains over the past two years.

This under-the-radar consumer staples stock boasts a Superscore of 78 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

Cameco generates $779M in annual free cash flow with a fortress balance sheet, while TMC burns cash in pursuit of unproven deep-sea technology.

C3.ai burns cash and carries a $1.8 billion accumulated deficit, while Atlassian generates $1.3 billion in free cash flow despite higher valuation multiples.

Novavax (NASDAQ:NVAX) executives outlined the company’s transition from a COVID-19 vaccine-focused business toward a partnership-driven model centered on its Matrix-M adjuvant technology, with near-term attention on Sanofi’s commercial rollout of NUVAXOVID, combination vaccine development and early

Can an extra $100 on the starting price outrun memory costs management itself expects to keep climbing?

Boeing's debt burden and negative cash flow contrast sharply with GE's fortress balance sheet and $7.3 billion in free cash flow.

Corning and Verizon signed a multi-year deal for over 80 million miles of optical fiber from 2027-2032, boosting broadband expansion and AI data center connectivity for both companies.

AbbVie's diversified portfolio faces patent headwinds, while Novo Nordisk dominates a faster-growing market, but one trades at a steeper valuation.

The executive's disposition follows a 16% decline in the stock price over the trailing 12 months.

The tech-heavy index's performance is likely to remain strong. It's also likely to remain volatile.

Chewy reported mixed second-quarter earnings that underwhelmed the market.

Axsome is already selling drugs with 65% revenue growth, while Viking bets on obesity treatments still in trials, a classic choice between proven sales and blockbuster potential.

The SOFC maker's latest upgrade will further accelerate its system deployments.

Nvidia is looking to extend its dominance in AI chips at the expense of Intel and AMD.

What Happened? A number of stocks fell in the afternoon session after the August Producer Price Index rose 5.4% year-over-year and crude oil climbed past $10...

What Happened? A number of stocks traded in opposite directions in the afternoon session after the August Producer Price Index rose 5.4% year-over-year and c...

Mark Reinstra executed $258,630 in stock sales under a Rule 10b5-1 trading plan, maintaining $27.5 million in total equity holdings across direct and trust-based positions.

Accelerating revenue growth has investors enthusiastic about Palantir stock.

Investors are curious whether The Trade Desk is a value stock or a value trap.

Veterinary laboratory testing can reveal health concerns that may not be obvious during a routine exam. Blood, urine, and other diagnostic tests help veter

What Happened? Shares of young adult apparel retailer American Eagle Outfitters (NYSE:AEO) fell 15.4% in the afternoon session despite strong second-quarter ...